Evofem Biosciences, Inc.
EVFM
$0.0097
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 131.48% | -28.41% | -275.06% | 128.09% | -127.48% |
| Total Depreciation and Amortization | -29.10% | 5.21% | 4,285.71% | -41.67% | -45.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -313.09% | 187.19% | 138.80% | -213.10% | 193.36% |
| Change in Net Operating Assets | 314.19% | -492.08% | 15,875.00% | -100.15% | -36.66% |
| Cash from Operations | 123.26% | -424.62% | 59.77% | -1,027.64% | 172.35% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -23.91% | 90.96% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -23.91% | 90.96% | -- | 100.00% | -- |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | 49.44% | -1.91% | -3.56% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Financing | -105.46% | 147.80% | -12.76% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,836.84% | -36.67% | 900.00% | -97.25% | -35.88% |